144 related articles for article (PubMed ID: 23154923)
1. Intrinsically copper-64-labeled organic nanoparticles as radiotracers.
Liu TW; MacDonald TD; Shi J; Wilson BC; Zheng G
Angew Chem Int Ed Engl; 2012 Dec; 51(52):13128-31. PubMed ID: 23154923
[TBL] [Abstract][Full Text] [Related]
2. Urokinase injection-triggered clearance enhancement of a 4-arm PEG-conjugated
Matsumura K; Zouda M; Wada Y; Yamashita F; Hashida M; Watanabe Y; Mukai H
Int J Pharm; 2018 Jul; 545(1-2):206-214. PubMed ID: 29746998
[TBL] [Abstract][Full Text] [Related]
3. New issues for copper-64: from precursor to innovative PET tracers in clinical oncology.
Evangelista L; Luigi M; Cascini GL
Curr Radiopharm; 2013 Sep; 6(3):117-23. PubMed ID: 23886447
[TBL] [Abstract][Full Text] [Related]
4. Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
Bioconjug Chem; 2010 May; 21(5):947-54. PubMed ID: 20402512
[TBL] [Abstract][Full Text] [Related]
5. Copper-64 labeled nanoparticles for positron emission tomography imaging: a review of the recent literature.
Capriotti G; Varani M; Lauri C; Franchi G; Pizzichini P; Signore A
Q J Nucl Med Mol Imaging; 2020 Dec; 64(4):346-355. PubMed ID: 33073558
[TBL] [Abstract][Full Text] [Related]
6. Integrin αvβ3-Targeted [
Cui L; Xiong C; Zhou M; Shi S; Chow DS; Li C
Bioconjug Chem; 2018 Dec; 29(12):4062-4071. PubMed ID: 30404438
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and Evaluation of New Generation Cross-Bridged Bifunctional Chelator for (64)Cu Radiotracers.
Dale AV; An GI; Pandya DN; Ha YS; Bhatt N; Soni N; Lee H; Ahn H; Sarkar S; Lee W; Huynh PT; Kim JY; Gwon MR; Kim SH; Park JG; Yoon YR; Yoo J
Inorg Chem; 2015 Sep; 54(17):8177-86. PubMed ID: 26286436
[TBL] [Abstract][Full Text] [Related]
8. Hybrid Metal-Phenol Nanoparticles with Polydopamine-like Coating for PET/SPECT/CT Imaging.
Suárez-García S; Esposito TVF; Neufeld-Peters J; Bergamo M; Yang H; Saatchi K; Schaffer P; Häfeli UO; Ruiz-Molina D; Rodríguez-Rodríguez C; Novio F
ACS Appl Mater Interfaces; 2021 Mar; 13(9):10705-10718. PubMed ID: 33635046
[TBL] [Abstract][Full Text] [Related]
9. A cell permeable peptide analog as a potential-specific PET imaging probe for prostate cancer detection.
Hao G; Zhou J; Guo Y; Long MA; Anthony T; Stanfield J; Hsieh JT; Sun X
Amino Acids; 2011 Nov; 41(5):1093-101. PubMed ID: 20221650
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and radiopharmacological evaluation of ⁶⁴Cu-labeled bombesin analogs featuring a bis(2-pyridylmethyl)-1,4,7-triazacyclononane chelator.
Bergmann R; Ruffani A; Graham B; Spiccia L; Steinbach J; Pietzsch J; Stephan H
Eur J Med Chem; 2013; 70():434-46. PubMed ID: 24184988
[TBL] [Abstract][Full Text] [Related]
11. Optimization, biological evaluation and microPET imaging of copper-64-labeled bombesin agonists, [64Cu-NO2A-(X)-BBN(7-14)NH2], in a prostate tumor xenografted mouse model.
Lane SR; Nanda P; Rold TL; Sieckman GL; Figueroa SD; Hoffman TJ; Jurisson SS; Smith CJ
Nucl Med Biol; 2010 Oct; 37(7):751-61. PubMed ID: 20870150
[TBL] [Abstract][Full Text] [Related]
12. Facile synthesis, pharmacokinetic and systemic clearance evaluation, and positron emission tomography cancer imaging of ⁶⁴Cu-Au alloy nanoclusters.
Zhao Y; Sultan D; Detering L; Luehmann H; Liu Y
Nanoscale; 2014 Nov; 6(22):13501-9. PubMed ID: 25266128
[TBL] [Abstract][Full Text] [Related]
13. Efficient synthesis of new tetradentate ligands with potential applications for 64Cu PET-imaging.
Bodio E; Julienne K; Gouin SG; Faivre-Chauvet A; Deniaud D
Bioorg Med Chem Lett; 2011 Feb; 21(3):924-7. PubMed ID: 21236669
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of 64Cu-labeled monomeric and dimeric NGR peptides for MicroPET imaging of CD13 receptor expression.
Chen K; Ma W; Li G; Wang J; Yang W; Yap LP; Hughes LD; Park R; Conti PS
Mol Pharm; 2013 Jan; 10(1):417-27. PubMed ID: 23190134
[TBL] [Abstract][Full Text] [Related]
15. PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.
Paterson BM; Roselt P; Denoyer D; Cullinane C; Binns D; Noonan W; Jeffery CM; Price RI; White JM; Hicks RJ; Donnelly PS
Dalton Trans; 2014 Jan; 43(3):1386-96. PubMed ID: 24202174
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of (64)Cu-labeled DOTA-D-Phe(1)-Tyr (3)-octreotide ((64)Cu-DOTA-TOC) for imaging somatostatin receptor-expressing tumors.
Hanaoka H; Tominaga H; Yamada K; Paudyal P; Iida Y; Watanabe S; Paudyal B; Higuchi T; Oriuchi N; Endo K
Ann Nucl Med; 2009 Aug; 23(6):559-67. PubMed ID: 19504168
[TBL] [Abstract][Full Text] [Related]
17. Inherently multimodal nanoparticle-driven tracking and real-time delineation of orthotopic prostate tumors and micrometastases.
Liu TW; Macdonald TD; Jin CS; Gold JM; Bristow RG; Wilson BC; Zheng G
ACS Nano; 2013 May; 7(5):4221-32. PubMed ID: 23544841
[TBL] [Abstract][Full Text] [Related]
18. PET imaging of prostate cancer xenografts with a highly specific antibody against the prostate-specific membrane antigen.
Elsässer-Beile U; Reischl G; Wiehr S; Bühler P; Wolf P; Alt K; Shively J; Judenhofer MS; Machulla HJ; Pichler BJ
J Nucl Med; 2009 Apr; 50(4):606-11. PubMed ID: 19289418
[TBL] [Abstract][Full Text] [Related]
19. Establishing Reliable Cu-64 Production Process: From Target Plating to Molecular Specific Tumor Micro-PET Imaging.
Xie Q; Zhu H; Wang F; Meng X; Ren Q; Xia C; Yang Z
Molecules; 2017 Apr; 22(4):. PubMed ID: 28420176
[TBL] [Abstract][Full Text] [Related]
20. Small-animal PET of tumors with (64)Cu-labeled RGD-bombesin heterodimer.
Liu Z; Li ZB; Cao Q; Liu S; Wang F; Chen X
J Nucl Med; 2009 Jul; 50(7):1168-77. PubMed ID: 19525469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
